Wu, F; Christen, P; Gehring, H (2011). A novel approach to inhibit intracellular vitamin B6-dependent enzymes: proof of principle with human and plasmodium ornithine decarboxylase and human histidine decarboxylase. FASEB Journal, 25(7):2109-2122.
Wu, F; Saleem, M A; Kampik, N B; Satchwell, T J; Williamson, R C; Blattner, S M; Ni, L; Toth, T; White, G; Young, M T; Parker, M D; Alper, S L; Wagner, C A; Toye, A M (2010). Anion exchanger 1 interacts with nephrin in podocytes. Journal of the American Society of Nephrology (JASN), 21(9):1456-1467.
Müller, I B; Wu, F; Bergmann, B; Knöckel, J; Walter, R D; Gehring, H; Wrenger, C (2009). Poisoning pyridoxal 5-phosphate-dependent enzymes: a new strategy to target the malaria parasite Plasmodium falciparum. PLoS ONE, 4(2):e4406.
Wu, F; Gehring, H (2009). Structural requirements for novel coenzyme-substrate derivatives to inhibit intracellular ornithine decarboxylase and cell proliferation. FASEB Journal, 23(2):565-574.
Wu, F; Yu, J; Gehring, H (2008). Inhibitory and structural studies of novel coenzyme-substrate analogs of human histidine decarboxylase. FASEB Journal, 22(3):890-897.
Wu, F; Grossenbacher, D; Gehring, H (2007). New transition state-based inhibitor for human ornithine decarboxylase inhibits growth of tumor cells. Molecular Cancer Therapeutics, 6(6):1831-1839.